Phase I data for Merck & Co. Inc. 's BACE1 inhibitor, verubecestat, were published earlier this week in Science Translational Medicine (STM) , spurring headlines that the first successful Alzheime
IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out